These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2008-003438-12 Ensayo Clínico aleatorizado para comparar la combinación ZDV + 3TC + ABC (Trizivir) frente a Lopinavir/R (Kaletra) en monoterapia en pacientes con supresión viral en tratamiento previo con ZDV + 3TC +... not-yet-due
Ongoing 2008-003748-12 “Estudio Fase IV-III, comparativo, aleatorizado y abierto para evaluar la eficacia para la recuperación de grasa periférica (o de extremidades) de lopinavir/ritonavir en monoterapia versus abacavir/la... not-yet-due
Completed, but no date 2010-023503-10 Ensayo clínico piloto, abierto, controlado y aleatorizado para evaluar la actividad de fosamprenavir frente al virus de la hepatitis C (VHC) genotipo 1 en pacientes coinfectados por el virus de la inm... bad-data
Completed, but no date 2011-000804-17 Randomized, multicentric, open label comparative trial to assess safety of Anidulafungina versus Anfotericina B Liposomal for antifungic profilaxis in high risk hepatic transplanted patients. AVALTRA ... bad-data
Ongoing 2011-001107-12 Ensayo Clínico aleatorizado, abierto, de no inferioridad y con seguimiento a 96 semanas sobre la eficacia de azatanavir / ritonavir + lamivudina como tratamiento de mantenimiento en pacientes con sup... not-yet-due
Completed, but no date 2012-001612-34 A prostective, with one site, open-label not controled trial, for the observation of treatment with CIDOFOVIR 1%, 3 nights per week, during 4 weeks, of Anal Intraephitelial Neoplasia, high level, in H... bad-data
Completed, but no date 2014-000515-14 Comparative, randomized, open study to evaluate maintenance with Darunavir/ritonavir once daily plus Lamivudine once daily versus continuing Darunavir/ritonavir once-daily plus Tenofovir/Emtricitabine... bad-data
Completed, report not yet due 2016-004646-29 A phase IV open- label, randomized and pilot clinical trial, designed to evaluate the potential neurotoxicity of dolutegravir/lamivudine/abacavir in neurosymptomatic HIV patients and their reversibil... 2019-04-23 not-yet-due
Not reported Terminated 2017-000432-34 A PHASE III, OPEN-LABEL, MULTICENTRIC CLINICAL TRIAL OF A SINGLE ARM OF 16 LENGTHS OF TIME TO EVALUATE RETENTION WITH ELBASVIR / GRAZOPREVIR PLUS SOFOSBUVIR AND RIBAVIRIN IN PATIENTS WITH HEPATITIS C ... 2017-06-23 due-trials
Ongoing 2017-004137-91 A single-arm, open-label, multicenter phase IV trial to evaluate the efficacy and safety of elvitegravir / cobicistat / emtricitabine / tenofovir alfa-namide as first-line treatment in naïve patients ... not-yet-due
Ongoing 2018-000215-24 A single-arm, open-label and multicentre phase IV trial to evaluate the immunogenicity of the nonavalent vaccine against human papillomavirus in HIV-infected men who have sex with men. GESIDA 10017 St... not-yet-due
Ongoing 2018-001158-82 Phase IV, Open Label, Randomized, Clinical Trial to Evaluate the Reversibility of abacavir/lamivudine/dolutegravir CNS-Related Neurotoxicity After Switching to tenofovir alafenamide/emtricitabine/daru... not-yet-due